Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 25
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/1/1988
1.
Phase II Master Protocol for New Agents in the Treatment of Advanced Colorectal Cancer --- Didemnin B (Summary Last Modified 05/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-86I3
NCI-T86-0292D, T86-0292
2.
Phase II Study of Chemotherapy with Didemnin B in Patients with Advanced, Measurable Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
MDA-DM-87021
NCI-T87-0071C, T87-0071
Last Modified:
8/1/1989
3.
Phase I/II Study of Chemotherapy with Didemnin B in Patients with non-Small Cell Lung Cancer (Summary Last Modified 08/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
15 and over
NCI
MDA-DM-87027
NCI-T87-0074C, T87-0074
Last Modified:
3/1/1990
4.
Phase II Randomized Evaluation of Chemotherapy with Didemnin B or Trimetrexate in Patients with Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix (Summary Last Modified 03/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
any age
NCI
SWOG-8640
SWOG-8640
Last Modified:
11/1/1992
5.
Phase II Chemotherapy with Didemnin B in Patients with Small Cell Lung Cancer (Summary Last Modified 11/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
15 and over
NCI
MDA-DM-87028
NCI-T87-0073C, T87-0073
Last Modified:
12/1/1990
6.
Phase II Chemotherapy with Didemnin B for Patients with Metastatic Breast Cancer (Summary Last Modified 12/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
16 and over
NCI
MDA-DM-87039
NCI-T87-0108C, T87-0108
Last Modified:
4/26/2007
7.
Phase II Chemotherapy with Didemnin B in Patients with Metastatic Adenocarcinoma of the Kidney (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-8728
SWOG-8728
Last Modified:
9/1/1988
8.
Phase II Chemotherapy with Didemnin B in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 09/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
MSKCC-8787A
NCI-T87-0193C, T87-0193
Last Modified:
10/15/2007
9.
Phase II Study of Didemnin B vs IFF/Mesna for Patients with Adenocarcinoma of the Prostate Resistant to Endocrine Treatment and of IFF/Mesna in Patients without Prior Endocrine Manipulation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-8719
SWOG-8719
Last Modified:
10/1/1989
10.
Phase II Chemotherapy with Didemnin B in Patients with Advanced Transitional Cell Carcinoma of the Bladder, Ureter, and Renal Pelvis (Summary Last Modified 10/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-87U3
NCI-T87-0206D, T87-0206
Select All on One Page
1
2
3
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute